Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2, with no changes to study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check32 days agoChange DetectedRemoved the government funding status notice that warned information on the site may not be up to date and directed users to opm.gov and cc.nih.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedNo additions or deletions were detected on the page; the content appears unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedUpgrade notice to v3.2.0 with a government-operating-status disclaimer; removal of v3.0.2 indicates the version update.SummaryDifference2%

- Check82 days agoChange DetectedThe page has updated the EMERALD trial entry with a new Phase 3 record dated 2025-09-15, replacing the previous 2024-10-30 version. Core trial details (design, endpoints, eligibility, arms) are retained but refreshed; minor wording and date formats updated. If no significant content changes beyond the update, note that this is an updated trial record rather than a new conceptual change.SummaryDifference3%

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.